cola lipid c efficacy against albicans Candida accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling Frontiers | Pore-forming peptide C14R
Frontiers Pore forming peptide C14R exhibits potent antifungal activity against clinical isolates of Candida albicans and Candida auris The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo Scientific Reports Candida albicans gains azole resistance by altering sphingolipid composition Nature Communications Nanostructured Lipid Carrier Based on Melaleuca Alternifolia and Bacuri Butter Associated with the Subdose of Amphotericin B: Cytotoxic and Antimicrobial Activity BioNanoScience Springer Nature Link Antifungal efficacy of pyrolysis derived bio oil aqueous phases from Tropical plant biomass against Candida auris Scientific Reports
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




